Nurse Practitioner in Villa Park, IL Accepting Medicare

9 Nurse Practitioner nurses found. Showing 1 - 9

Nina Rusiana, APN Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 200 E Roosevelt Rd, Villa Park, IL 60181 Phone: 866-825-3227

Valerie Baron, APN Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 200 E Roosevelt Rd, Villa Park, IL 60181 Phone: 800-323-8622

Kezia Philips, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 622 N Addison Rd, Villa Park, IL 60181 Phone: 630-279-9600

Julie K Miyamasu, APN-CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 200 E Roosevelt Rd, Villa Park, IL 60181 Phone: 800-323-8622

Jennifer Tiffen, APN Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 200 E Roosevelt Road, Villa Park, IL 60181 Phone: 866-825-3227

Kristina A Roscizewski, NP Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 200 E Roosevelt Rd, Villa Park, IL 60181 Phone: 630-993-0869

Tanya M Lechmaier, APNP Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 200 E Roosevelt Rd, Villa Park, IL 60181 Phone: 800-323-8622

Stephanie Nicole Pelling, APN Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 1s219 Ingersoll Ln, Villa Park, IL 60181 Phone: 630-699-8234

Mrs. Faye Saldana Pantaleon Burnham, RNC, ARNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 200 E Roosevelt Rd, Villa Park, IL 60181 Phone: 877-229-1006

News Archive

Persistent lung inflammation from childhood asthma may increase risk of anxiety later in life

Persistent lung inflammation may be one possible explanation for why having asthma during childhood increases your risk for developing anxiety later in life, according to Penn State researchers.

AVIS donates health research project focuses on cancer biomarkers

The greatest research project on cancer biomarkers is to start in the next months. The new scientific research will open new frontiers in the field of prevention of two most relevant cancer: prostate cancer and ovarian cancer. The research project, which also includes an important prevention programme, is named "AVIS donates health" (AVIS is the Italian most important blood donors association) and is supported by Fondazione Abo - Application of biotechnologies in Oncology, Avis, Lilt (Italiana League for the fight against cancer) and by the three scientific societies of gynecologists and urologists.

Iverson Genetic Diagnostics receives CMS approval for Warfarin clinical study

Iverson Genetic Diagnostics today announced the company has received approval from CMS to conduct a WARFARIN Clinical Study. The two-year (2) study will assess the impact of genetic information in calculating doses and the changes in the rate of adverse events when initiating Warfarin drug therapy. These changes will be compared against doses initiated without genetic data. The randomized and blinded, multi-center study will involve more than 7000 participants at over 50 sites nationwide.

Positive results for AstraZeneca's PARP inhibitor Lynparza in advanced breast cancer

A new study has shown that AstraZeneca's Lynparza (olaparib) can significantly slow the progress of breast cancer that is caused partially due to mutations of the culprit gene called BRCA. BRCA gene mutations are responsible for around 3% of all breast cancers. These cases of the disease that have a basis in the gene are notoriously difficult to treat and women who are tested positive for this gene may even opt for removal of their breasts before even the cancer strikes. Noted actress Angelina Jolie went for a similar prophylactic mastectomy.

Read more Medical News

› Verified 7 days ago